Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Pfizer"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer."

12 result(s) displayed (1 - 12 of 40)


ING raises $1.3B in U.S. debut

The EC-mandated divestment leaves the parent company with a 75% holding in the unit, which it plans to exit over time. Continue reading

Posted on May 3, 2013 8:58 AM




This video is exclusive to The Deal Pipeline

Nestle wins Pfizer nutrition business

Take an in-depth look at Nestle's winning $11.85 billion bid for Pfizer's nutrition unit.
Posted on April 23, 2012 12:09 PM



This video is exclusive to The Deal Pipeline

Pfizer plays small ball with Alacer bolt-on

Take an in-depth look at Pfizer's deal for vitamin maker Alacer for an undisclosed sum as it beefs up its healthcare unit.
Posted on February 28, 2012 12:05 PM



Biotech billionaire: Meet Randal J. Kirk

R.J. Kirk has quietly built a sterling record investing in and running some of the riskiest businesses around -- and he's done it from bucolic southwestern Virginia. Continue reading

Posted on June 24, 2011 1:11 PM




Big Pharma: Pfizer, Merck, Wyeth and more

The pharmaceutical industry has seen a ton of deals over the past few years, some $230 billion in M&A activity from the top 10 pharmaceutical companies alone since the beginning of 2007. Continue reading

Posted on March 9, 2010 9:13 AM




On M&A and layoffs

The connection is so obvious we tend not to think about it too much. We should, though. Continue reading

Posted on December 11, 2009 12:00 PM




Scenes from the slowdown

M&A activity may have stalled during the first half of the year, but deal lawyers still had plenty to talk about. Continue reading

Posted on August 7, 2009 10:56 AM




Morphing models

A conversation with former Pfizer, now University of California, San Francisco, biotech veteran Corey Goodman. Continue reading

Posted on August 7, 2009 10:36 AM




Deep cleansing treatment

As Pfizer prepares for another digestive challenge in the form of Wyeth, it is trying to unload some compounds it already has. Continue reading

Posted on June 5, 2009 11:54 AM




Promoting healthy dealflow

How contingent value rights bridge gaps between buyers and sellers in the healthcare industry. Continue reading

Posted on May 19, 2009 3:00 PM




The marriage of theory and practice

Abigail Barrow and Steven Shapin on the interaction of science, technology and economic development. Continue reading

Posted on May 15, 2009 11:59 AM




That's a spicy meatball

Skepticism abounds over Pfizer's ability to digest Wyeth. Continue reading

Posted on April 17, 2009 1:18 PM




1 2 3 4 Next

Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors